M&T Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4
Closed -$1K 1655
2022
Q3
$1K Hold
4
﹤0.01% 1611
2022
Q2
$5K Buy
+4
New +$1.2K ﹤0.01% 1574
2019
Q2
Sell
-6
Closed -$2K 1651
2019
Q1
$2K Buy
6
+2
+50% +$243 ﹤0.01% 1568
2018
Q4
$10K Hold
4
﹤0.01% 1400
2018
Q3
$7K Hold
4
﹤0.01% 1521
2018
Q2
$1K Buy
+4
New +$329 ﹤0.01% 1545
2016
Q3
Sell
-4
Closed -$1K 1754
2016
Q2
$1K Buy
+4
New +$301 ﹤0.01% 1680

Other funds holding LLY

M&T Bank's LLY Position: Q2 2026 in Review

M&T Bank increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $17M and bringing the position to 261,864 shares worth $314M. The position accounts for 0.92% of the portfolio, ranked #22.

M&T Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • M&T Bank held 261,864 shares of Eli Lilly worth $314M as of Q2 2026.
  • M&T Bank bought 16,604 Eli Lilly shares in Q2 2026, an estimated $17M.
  • Eli Lilly made up 0.92% of M&T Bank's portfolio in Q2 2026, its #22 holding.
  • M&T Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.